Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. 1992

G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
Critical Care Medicine Department, Warren G Magnuson Clinical Centre, National Institutes of Health, Bethesda, Maryland 20814.

Detection of Pneumocystis carinii by the polymerase chain reaction (PCR) may facilitate non-invasive diagnosis of P carinii pneumonia and study of its epidemiology. We have compared the sensitivity and specificity of two PCR methods with those of conventional staining for detection of P carinii in induced sputum, bronchoalveolar lavage fluid (BAL), and blood. Of 71 sputum samples, 17 were from patients with microbiologically confirmed P carinii pneumonia. A nested PCR method correctly identified the presence of P carinii in all 17 (100% sensitive, 95% confidence interval [CI] 81-100%) and found no organisms in 50 of 54 microbiologically negative samples (93% specific, 95% CI 82-98%). PCR with a single primer pair was 71% sensitive (44-90%) and 94% specific (85-99%). The sensitivity of conventional staining methods (direct and indirect fluorescence antibody and toluidine-blue-O tests) was significantly less (38-53%) than that of nested PCR (p less than 0.05). In BAL, neither PCR method was significantly better than the conventional staining methods. P carinii was detected in BAL or sputum from 10 immunocompromised patients without microbiological evidence of P carinii pneumonia, which suggests that symptom-free carriers or subclinical infection can exist. P carinii was detected by nested PCR in blood from 2 of 3 patients with disseminated pneumocystosis but in only 1 of 11 patients with P carinii infection restricted to the lungs. Nested PCR on induced sputum is more sensitive than conventional staining methods for the diagnosis of P carinii pneumonia and provides a non-invasive method of detecting disseminated disease.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011010 Pneumocystis A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS. Pneumocysti
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced

Related Publications

G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
May 1993, Internal medicine (Tokyo, Japan),
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
January 1995, Scandinavian journal of infectious diseases,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
February 1993, Journal of clinical microbiology,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
August 1996, Journal of clinical microbiology,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
December 1993, Molecular and cellular probes,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
October 1993, Journal of clinical microbiology,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
January 1991, The Journal of protozoology,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
September 1998, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
April 1992, Molecular and cellular probes,
G Y Lipschik, and V J Gill, and J D Lundgren, and V A Andrawis, and N A Nelson, and J O Nielsen, and F P Ognibene, and J A Kovacs
September 2002, Zhonghua nei ke za zhi,
Copied contents to your clipboard!